Howard Hughes Medical Institute’s Monsanto Co MON Stock Holding History

Howard Hughes Medical Institute’s Portfolio MON Stock Details MON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,481	Closed	-$294K	–	150
2017 Q2	$294K	Sell	2,481 -505	-17%	-$58.9K	0.05%	116
2017 Q1	$338K	Buy	+2,986	New	+$330K	0.06%	103
2016 Q2	–	Sell	-1,256	Closed	-$110K	–	188
2016 Q1	$110K	Buy	+1,256	New	+$113K	0.02%	132
2015 Q1	–	Sell	-627	Closed	-$75K	–	199
2014 Q4	$75K	Sell	627 -3,775	-86%	-$438K	0.02%	147
2014 Q3	$495K	Buy	4,402 +3,258	+285%	+$381K	0.11%	78
2014 Q2	$143K	Sell	1,144 -56,163	-98%	-$6.57M	0.02%	106
2014 Q1	$6.52M	Sell	57,307 -1,138	-2%	-$127K	0.93%	17
2013 Q4	$6.81M	Buy	58,445 +1,200	+2%	+$131K	1.03%	19
2013 Q3	$5.97M	Sell	57,245 -89	-0.2%	-$8.94K	0.92%	19
2013 Q2	$5.67M	Buy	+57,334	New	+$6M	1.86%	24

Other funds holding MON

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Howard Hughes Medical Institute's MON Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of Monsanto Co (MON) in Q3 2017, closing a stake of 2,481 shares — an estimated $294K sold.

Howard Hughes Medical Institute first reported a position in MON in Q2 2013 and held it in 10 quarters. The position peaked at $6.81M in Q4 2013. 1,033 funds tracked by Wall St. Rank hold MON as of Q3 2017.

Howard Hughes Medical Institute reported no remaining Monsanto Co position as of Q3 2017 after selling out during the quarter.
Howard Hughes Medical Institute sold 2,481 Monsanto Co shares in Q3 2017, an estimated $294K.
Howard Hughes Medical Institute first reported a position in Monsanto Co in Q2 2013 and held it in 10 quarters.
Howard Hughes Medical Institute's Monsanto Co position peaked at $6.81M in Q4 2013.
1,033 funds tracked by Wall St. Rank held Monsanto Co as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.